CPS1は,KRAS/LKB1変異性肺がん細胞におけるピリミジンプールとDNA合成を維持する
Jiyeon Kim1, Zeping Hu1, Ling Cai1
1Children's Medical Center Research Institute, UT Southwestern Medical Center, Dallas, Texas 75390, USA.
Nature
|May 25, 2017
まとめ
KRASおよびLKB1変異を有する攻撃的な非小細胞肺がんは,ピリミジン合成のためにカルバモイルリン酸合成-1 (CPS1) に依存しています. CPS1を阻害すると,ピリミドインを枯渇させ,細胞死を引き起こし,潜在的な治療標的となる.
科学分野:
- 腫瘍学
- 癌 代謝
- 分子生物学
背景:
- KRAS変異を含む腫瘍性信号は,がんの発症と進行に不可欠な代謝再プログラムを駆動する.
- 非小細胞肺がん (NSCLC) はしばしばKRASと腫瘍抑制剤STK11 (LKB1をコードする) の変異を宿し,同時に発生する変異 (KL) は攻撃的な疾患に関連している.
- 特に窒素処理における代謝の調節障害は,KL NSCLCの特徴です.
研究 の 目的:
- KRASとLKB1変異 (KL) が併発した攻撃的な非小細胞肺がん (NSCLC) の代謝変化を調査する.
- KL NSCLC細胞の窒素代謝におけるカルバモイルリン酸合成-1 (CPS1) の役割とその腫瘍成長への影響を明らかにする.
- KL NSCLCにおける観察された代謝再プログラムに関連した潜在的な治療的脆弱性を特定する.
主な方法:
- ヒトのKL細胞と腫瘍の比較代謝分析により,代謝経路の障害を特定する.
- カルバモイルリン酸合成酵素-1 (CPS1) の発現と,NSCLCにおけるLKB1/AMPK信号によるその調節の調査.
- 細胞死,腫瘍増殖,DNA損傷を評価するために,KL細胞におけるCPS1静止と外因的なピリミジン補給を含む機能研究.
主要な成果:
- KL細胞と腫瘍は,カルバモイルリン酸合成-1 (CPS1) の発現を含む,変化した窒素処理によって特徴づけられるユニークな代謝シグネチャーを示します.
- LKB1はAMPK経由でCPS1の転写を抑制し,CPS1の発現はヒトのNSCLCにおけるLKB1レベルと逆相関する.
- KL細胞のCPS1を静止することは,アンモニアの毒性ではなく,ピリミジン枯渇による細胞死につながり,DNA合成を危うくし,DNA損傷を引き起こすことで腫瘍の成長を減少させます.
結論:
- KL腫瘍性遺伝子型は,非従来の窒素からピリミジンへの代謝経路に依存する,攻撃的なNSCLCにおいて代謝の脆弱性を生み出します.
- CPS1は,KL NSCLCにおける急速な細胞増殖のためのピリミジン供給において重要な役割を果たします.
- CPS1またはピリミジン合成経路を標的とした治療は,この攻撃的なNSCLCの治療戦略として有望である.
関連する概念動画
Abnormal Proliferation
5.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Inhibition of Cdk Activity
6.1K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
DNA Damage can Stall the Cell Cycle
10.3K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.3K
DNA Damage Can Stall the Cell Cycle
3.3K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.3K
The Ras Gene
7.4K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
7.4K
Negative Regulator Molecules
38.7K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.7K


